$CASI CASI Pharmaceuticals, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CASI Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CASI Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in CASI Pharmaceuticals, Inc. for free.
IRS Number: 581959440
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: CASI
Company Address: 9620 MEDICAL CENTER DR STE 300 ROCKVILLE 20850
Phone number: (240)-864-2600
Former name: ENTREMED INC, date of change: 1996-04-15
Market Capitalization: $81.26M
Prev close: $1.39
Average Daily Volume: 52,416
Days Low: $1.30
Year Low: $0.75
Year High: $1.76
CASI Pharmaceuticals, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2021 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 2.05 | 3,000,000 | 6,150,000 | 3,000,000 | 0 to 3 M |
| Dec 23 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Gift | G | 0.00 | 380,000 | 0 | 4,683,994 | 5.1 M to 4.7 M (-7.50 %) |
| Dec 18 2020 | CASI | CASI Pharmaceutica ... | Xu Weihao | Chief Financial Off ... | Option Exercise | A | 2.61 | 800,000 | 2,088,000 | 800,000 | |
| Dec 18 2020 | CASI | CASI Pharmaceutica ... | Xu Weihao | Chief Financial Off ... | Buy | P | 2.63 | 2,279 | 5,994 | 10,000 | 7.7 K to 10 K (+29.52 %) |
| Dec 18 2020 | CASI | CASI Pharmaceutica ... | Xu Weihao | Chief Financial Off ... | Buy | P | 2.64 | 1,721 | 4,543 | 7,721 | 6 K to 7.7 K (+28.68 %) |
| Dec 18 2020 | CASI | CASI Pharmaceutica ... | Xu Weihao | Chief Financial Off ... | Buy | P | 2.44 | 2,000 | 4,880 | 6,000 | 4 K to 6 K (+50.00 %) |
| Nov 24 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 2.18 | 100,000 | 218,000 | 5,063,994 | 5 M to 5.1 M (+2.01 %) |
| Nov 24 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 2.12 | 127,471 | 270,239 | 4,963,994 | 4.8 M to 5 M (+2.64 %) |
| Jul 24 2020 | CASI | CASI Pharmaceutica ... | Zhang Larry | President | Buy | P | 1.90 | 20,153 | 38,291 | 20,153 | 0 to 20.2 K |
| Jul 24 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 1.90 | 1,200,000 | 2,280,000 | 7,532,347 | 6.3 M to 7.5 M (+18.95 %) |
| Jul 24 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 1.90 | 2,952,426 | 5,609,609 | 4,836,523 | 1.9 M to 4.8 M (+156.70 %) |
| Jun 18 2020 | CASI | CASI Pharmaceutica ... | Zhou Quan | Director | Option Exercise | A | 2.63 | 67,429 | 177,338 | 67,429 | |
| Jun 18 2020 | CASI | CASI Pharmaceutica ... | Huang James | Director | Option Exercise | A | 2.63 | 70,400 | 185,152 | 70,400 | |
| Jun 18 2020 | CASI | CASI Pharmaceutica ... | Wu Yue Alexander | Director | Option Exercise | A | 2.63 | 68,800 | 180,944 | 68,800 | |
| Jun 18 2020 | CASI | CASI Pharmaceutica ... | Salisbury Franklin Cary jr | Director | Option Exercise | A | 2.63 | 68,800 | 180,944 | 68,800 |